SRC and neuroblastoma: As a note of caution, in the light of possible therapeutic developments in pre-clinical and in the clinic for NB, and also considering the numerous studies that have already investigated Src as antitumor target, we think that our data could be mainly useful for proposing new combination therapy, in which signaling pathways different from Src are also targeted.